BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/1/2014 5:04:00 PM | Browse: 1157 | Download: 1387
 |
Received |
|
2013-09-28 22:08 |
 |
Peer-Review Started |
|
2013-09-30 09:28 |
 |
To Make the First Decision |
|
2013-10-14 21:05 |
 |
Return for Revision |
|
2013-10-17 11:23 |
 |
Revised |
|
2013-11-12 15:28 |
 |
Second Decision |
|
2014-01-15 20:22 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-01-15 20:39 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-02-28 13:47 |
 |
Publish the Manuscript Online |
|
2014-03-12 14:46 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Autobiography |
Article Title |
Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats
|
Manuscript Source |
Invited Manuscript |
All Author List |
Kosuke Tanaka, Yuko Masaki, Masatake Tanaka, Masayuki Miyazaki, Munechika Enjoji, Makoto Nakamuta, Masaki Kato, Masatoshi Nomura, Toyoshi Inoguchi, Kazuhiro Kotoh and Ryoichi Takayanagi |
Funding Agency and Grant Number |
|
Corresponding Author |
Masaki Kato, MD, Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. mkato11@intmed3.med.kyushu-u.ac.jp |
Key Words |
Adipose tissue; Energy expenditure; Exenatide; Glucagon-like peptide-1; Hepatic steatosis; Lipolysis; Nonalcoholic fatty liver disease |
Core Tip |
Glucagon-like peptide-1 (GLP-1) is reported to improve nonalcoholic fatty liver disease (NAFLD), mainly via direct action on the liver. However, organs other than the liver may also be involved in regulation of hepatic lipid contents. In this study, we found significant upregulation of lipolytic genes in adipose tissue in exenatide-treated NAFLD rats. Up-regulation of catalase, superoxide dismutase and mitochondrial morphological regulators was observed in adipose tissue. These metabolic changes were accompanied by increased oxygen consumption and decreased respiratory exchange ratio. Taken together, enhanced lipid use by GLP-1 in adipose tissue may play an important role in the improvement of NAFLD. |
Publish Date |
2014-03-12 14:46 |
Citation |
Tanaka K, Masaki Y, Tanaka M, Miyazaki M, Enjoji M, Nakamuta M, Kato M, Nomura M, Inoguchi T, Kotoh K, Takayanagi R. Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats. World J Gastroenterol 2014; 20(10): 2653-2663 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i10/2653.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i10.2653 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345